The FDA has proposed to withdraw its approval of avacopan for ANCA-associated vasculitis, alleging that employees of the ...
Morning Overview on MSN
FDA says "manipulated" data backed approval, moves to withdraw the drug
The FDA has moved to pull Tavneos (avacopan) from the U.S. market, alleging that manipulated clinical trial data propped up the drug’s 2021 approval for a rare and potentially fatal blood vessel ...
On May 13, the Food and Drug Administration (FDA) approved decitabine and cedazuridine (Inqovi) tablets in combination with ...
Morning Overview on MSN
The FDA just cleared a new kind of br...
For roughly four in every ten women whose estrogen receptor-positive breast cancer has spread and stopped responding to ...
An official from the US Food and Drug Administration (FDA) on Monday presented three case studies demonstrating how sponsors effectively utilized real-world evidence (RWE) and real-world data (RWD) to ...
The Food and Drug Administration is asking Eli Lilly to gather more safety data on its new weight loss pill, Foundayo, including whether it could be linked to liver and heart problems, according to ...
Foundation Medicine previously received companion diagnostic approval for its FoundationOne Liquid CDx assay alongside EMD Serono's Tepmetko.
The U.S. Food and Drug Administration's decision to withhold approval of a new skin cancer treatment fell like a hammer on ...
Health system pharmacists and clinicians are monitoring a wave of drug approvals expected throughout 2026, including first-in-class therapies and expanded uses of existing drugs with implications for ...
For manufacturers, medical device companies, and laboratories that use the commercial diagnostic tests they produce, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results